+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Actinium-225 Market - Global Forecast 2026-2032- Product Image
Actinium-225 Market - Global Forecast 2026-2032- Product Image
Sale

Actinium-225 Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6141844
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Actinium-225 Market is projected to reach USD 777.52 Million in 2026. It is expected to continue growing at a CAGR of 5.60%, reaching USD 1.07 Billion by 2032.

Actinium-225: Executive Summary of a Targeted Radiopharmaceutical Isotope

Actinium-225 is an alpha-emitting radionuclide attracting attention for targeted alpha therapy, an approach designed to deliver highly destructive radiation to selected cancer cells while limiting exposure to surrounding tissue. Its clinical and commercial relevance depends on reliable isotope production, validated radiolabeling, suitable targeting molecules, specialized handling, and evidence from well-controlled studies. The field remains technically demanding because therapeutic performance must be matched with dependable supply, patient-selection strategies, and compliant clinical delivery systems.

From Experimental Promise to Integrated Therapeutic Systems

The landscape is shifting from isolated isotope-development efforts toward integrated platforms combining radionuclide production, chelator chemistry, targeting agents, dosimetry, manufacturing, and clinical operations. Greater emphasis is being placed on supply-chain resilience, reproducible pharmaceutical quality, and treatment-center readiness. Regulatory expectations are also encouraging developers to demonstrate not only biological activity but consistent product quality, manageable radiation safety, and clinically meaningful patient outcomes.

Artificial Intelligence Strengthens Discovery, Development, and Delivery

Artificial intelligence can support Actinium-225 programs by identifying promising molecular targets, optimizing chelator and linker designs, analyzing imaging and pathology data, and improving patient stratification. In clinical development, machine-learning tools may help refine dosimetry, detect treatment-response patterns, and support trial recruitment. These applications require representative datasets, transparent validation, human oversight, and controls against bias; AI should augment radiopharmaceutical expertise rather than replace laboratory, clinical, or regulatory judgment.

Regional Differences Shape Actinium-225 Readiness

North America combines advanced oncology research, radiopharmaceutical infrastructure, and specialized clinical centers, while Europe benefits from coordinated scientific networks and established nuclear-medicine capabilities. Asia-Pacific is building capacity across isotope production, precision oncology, and clinical research, with Japan, China, South Korea, India, and Australia contributing distinct strengths. Latin America is developing access through selected academic and clinical hubs. The Middle East is investing in healthcare modernization and nuclear-medicine capability, while Africa faces wider infrastructure and workforce constraints, making partnerships, training, and dependable logistics especially important.

International Groups Influence Standards, Supply, and Collaboration

ASEAN cooperation can support shared training, referral pathways, and regional access to specialized radiopharmaceutical services. BRICS members bring substantial scientific, manufacturing, and healthcare diversity, although coordination and regulatory alignment remain important. The European Union can leverage common research and regulatory frameworks, while the G7 offers strong capabilities in oncology, isotope science, and advanced manufacturing. GCC states are developing high-end healthcare capacity, and NATO members can contribute to resilient logistics, emergency planning, and cross-border scientific collaboration without conflating defense coordination with clinical governance.

Country Capabilities Differ Across the Development Chain

The United States and Canada have strong oncology research and radiopharmacy ecosystems. Germany, France, Italy, Spain, and the United Kingdom contribute established nuclear-medicine, academic, and regulatory capabilities, while broader European coordination can facilitate multicenter work. China, Japan, South Korea, and India are expanding capabilities in isotope science, biotechnology, and precision medicine. Australia offers advanced clinical research and radiopharmaceutical expertise. Brazil and Mexico provide important Latin American oncology and research hubs, while Russia retains relevant nuclear-science capabilities; in every country, dependable production, qualified personnel, and compliant clinical infrastructure remain decisive.

Prioritize Supply Resilience, Evidence Quality, and Treatment-Center Readiness

Industry leaders should diversify production routes and precursor access, establish rigorous quality-control systems, and design logistics around the isotope’s short effective working window. Development programs should align targeting biology, dosimetry, companion imaging, and clinical endpoints from the outset. Partnerships with hospitals, academic laboratories, regulators, and patient groups can improve trial execution and access planning. Leaders should also invest in workforce training, radiation-safety systems, transparent AI governance, and lifecycle monitoring so that promising therapies can be delivered consistently and responsibly.

Methodology for a Data-Grounded Actinium-225 Assessment

This executive summary uses a structured qualitative assessment of Actinium-225’s therapeutic role, development requirements, enabling technologies, and geographic readiness. The analysis organizes evidence around production, radiochemistry, targeted alpha therapy, clinical translation, regulation, infrastructure, and responsible AI adoption. Regional, group, and country observations are framed as capability and ecosystem considerations rather than quantitative rankings. No market estimates, market shares, forecasts, or company-specific claims are used.

Execution Discipline Will Determine Clinical Impact

Actinium-225 offers a compelling platform for targeted alpha therapy, but its impact will depend on more than isotope availability. Success requires coordinated progress in production, chemistry, targeting, dosimetry, clinical evidence, manufacturing, safety, and patient access. Regions and countries with integrated capabilities may advance more efficiently, while international collaboration can help address infrastructure and supply constraints. A disciplined, evidence-led approach will be essential to convert scientific potential into reliable clinical benefit.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Actinium-225 Market, by Indication
7.1. Introduction
7.2. Neuroendocrine Tumors
7.3. Prostate Cancer
8. Actinium-225 Market, by Product Type
8.1. Introduction
8.2. Antibody Conjugates
8.2.1. Bispecific Antibodies
8.2.2. Monoclonal Antibodies
8.3. Peptide Conjugates
8.4. Small Molecule Conjugates
9. Actinium-225 Market, by End User
9.1. Introduction
9.2. Hospital
9.2.1. Private Hospital
9.2.2. Public Hospital
9.3. Research Institute
9.4. Specialty Clinic
10. Actinium-225 Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributor
10.3.1. National Distributor
10.3.2. Regional Distributor
10.4. Online Pharmacy
11. Actinium-225 Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Actinium-225 Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Actinium-225 Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Actinium Pharmaceuticals, Inc.
15.2. Advanced Accelerator Applications S.A.
15.3. Curium Pharma SAS
15.4. Eckert & Ziegler Radiopharma GmbH
15.5. ITM Isotope Technologies Munich SE
15.6. JSC Isotope
15.7. Jubilant Radiopharma Services Inc.
15.8. Nordion (Canada) Inc.
15.9. Orano Med SAS
15.10. RayzeBio, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Actinium-225 Market, Years Considered for the Study
FIGURE 2. Global Actinium-225 Market, Research Design
FIGURE 3. Global Actinium-225 Market, Research Framework
FIGURE 4. Global Actinium-225 Market, Data Triangulation
FIGURE 5. Global Actinium-225 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Actinium-225 Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Actinium-225 Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Actinium-225 Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Actinium-225 Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Actinium-225 Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Actinium-225 Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Actinium-225 Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Actinium-225 Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Actinium-225 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Actinium-225 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Actinium-225 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Actinium-225 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Actinium-225 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Actinium-225 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Actinium-225 Market Segmentation & Coverage
TABLE 2. Global Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Neuroendocrine Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Neuroendocrine Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Neuroendocrine Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 11. Global Antibody Conjugates Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Antibody Conjugates Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Antibody Conjugates Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Bispecific Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Bispecific Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Bispecific Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Peptide Conjugates Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Peptide Conjugates Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Peptide Conjugates Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Small Molecule Conjugates Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Small Molecule Conjugates Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Small Molecule Conjugates Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 27. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Research Institute Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Research Institute Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Research Institute Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 43. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global National Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global National Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global National Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Regional Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Regional Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Regional Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 67. North America Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. North America Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 69. North America Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 71. North America Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. North America Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 73. North America Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. North America Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 75. Latin America Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 77. Latin America Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. Latin America Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 79. Latin America Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Latin America Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 81. Latin America Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Latin America Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 83. Europe Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Europe Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 85. Europe Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Europe Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 87. Europe Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Europe Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 89. Europe Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Europe Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 91. Middle East Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Middle East Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 93. Middle East Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. Middle East Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 95. Middle East Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Middle East Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 97. Middle East Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Middle East Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 99. Africa Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Africa Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Africa Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Africa Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 103. Africa Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Africa Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 105. Africa Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Africa Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 107. Global Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. ASEAN Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 110. ASEAN Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. ASEAN Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 112. ASEAN Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. ASEAN Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 114. ASEAN Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. ASEAN Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 116. GCC Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. GCC Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 118. GCC Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. GCC Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 120. GCC Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. GCC Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 122. GCC Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. GCC Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 124. European Union Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. European Union Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 126. European Union Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. European Union Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 128. European Union Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. European Union Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 130. European Union Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. European Union Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 132. BRICS Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. BRICS Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 134. BRICS Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. BRICS Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 136. BRICS Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. BRICS Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 138. BRICS Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. BRICS Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 140. G7 Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. G7 Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. G7 Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. G7 Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 144. G7 Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. G7 Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 146. G7 Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. G7 Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 148. NATO Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. NATO Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. NATO Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. NATO Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 152. NATO Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. NATO Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 154. NATO Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. NATO Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 156. Global Actinium-225 Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. United States Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 158. United States Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. United States Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. United States Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 161. United States Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. United States Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 163. United States Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. United States Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 165. Canada Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 166. Canada Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 167. Canada Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Canada Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 169. Canada Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Canada Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 171. Canada Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Canada Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 173. Mexico Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 174. Mexico Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 175. Mexico Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Mexico Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 177. Mexico Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Mexico Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 179. Mexico Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Mexico Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 181. Brazil Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 182. Brazil Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 183. Brazil Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Brazil Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 185. Brazil Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Brazil Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 187. Brazil Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Brazil Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 189. United Kingdom Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 190. United Kingdom Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 191. United Kingdom Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. United Kingdom Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 193. United Kingdom Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. United Kingdom Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 195. United Kingdom Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. United Kingdom Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 197. Germany Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 198. Germany Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 199. Germany Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Germany Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 201. Germany Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Germany Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 203. Germany Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Germany Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 205. France Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 206. France Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 207. France Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. France Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 209. France Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. France Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 211. France Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. France Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 213. Russia Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 214. Russia Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. Russia Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Russia Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 217. Russia Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Russia Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 219. Russia Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Russia Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 221. Italy Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 222. Italy Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 223. Italy Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Italy Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 225. Italy Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Italy Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 227. Italy Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Italy Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 229. Spain Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 230. Spain Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 231. Spain Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Spain Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 233. Spain Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Spain Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 235. Spain Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Spain Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 237. China Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 238. China Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 239. China Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. China Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 241. China Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. China Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 243. China Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. China Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 245. India Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 246. India Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 247. India Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. India Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 249. India Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. India Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 251. India Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. India Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 253. Japan Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 254. Japan Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 255. Japan Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. Japan Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 257. Japan Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Japan Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 259. Japan Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Japan Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 261. Australia Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 262. Australia Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 263. Australia Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Australia Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 265. Australia Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Australia Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 267. Australia Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Australia Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 269. South Korea Actinium-225 Market Size, 2017-2032 (USD Million)
TABLE 270. South Korea Actinium-225 Market Size, by Indication, 2017-2032 (USD Million)
TABLE 271. South Korea Actinium-225 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. South Korea Actinium-225 Market Size, by Antibody Conjugates, 2017-2032 (USD Million)
TABLE 273. South Korea Actinium-225 Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. South Korea Actinium-225 Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 275. South Korea Actinium-225 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. South Korea Actinium-225 Market Size, by Distributor, 2017-2032 (USD Million)
TABLE 277. Global Actinium-225 Market Share, by Key Player, 2025
TABLE 278. Global Actinium-225 Market, Key Experts

Companies Mentioned

  • Actinium Pharmaceuticals, Inc.
  • Advanced Accelerator Applications S.A.
  • Curium Pharma SAS
  • Eckert & Ziegler Radiopharma GmbH
  • ITM Isotope Technologies Munich SE
  • JSC Isotope
  • Jubilant Radiopharma Services Inc.
  • Nordion (Canada) Inc.
  • Orano Med SAS
  • RayzeBio, Inc.

Related Topics

Related Reports

Radiopharmaceutical Therapy Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceutical Therapy Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Alpha Emitters Market - Global Forecast 2026-2032 - Product Image

Alpha Emitters Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Alpha Emitters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Alpha Emitters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 185 Pages
  • Global
From
Actinium-225 Therapeutic Radioisotope - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Actinium-225 Therapeutic Radioisotope - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.